4Filing Date: Sep 29, 2026
Tempus AI
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0002113721-26-000018
Total Value$873.9K
Trades1
Insiders1
Transaction Details
Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-10.28K
Price$85.00
Total Value$873.9K
Shares Owned After76.74K
Transaction DateSep 25, 2026
10b5-1
Footnotes ▸
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
Post-Transaction Holdings
Schoenherr Thomas Edward · CEO, Diagnostics
| Security | Shares | Change |
|---|---|---|
| Class A Common Stock | 76.74K | -10.28K (-11.81%) |
auto_awesomeDeep Analysis
Deep Analysis
Tempus AI diagnostics CEO Thomas Schoenherr sold 10,281 Class A shares for $874K at $85.00 under a Rule 10b5-1 plan, cutting his direct stake by about 12%.
lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-25
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Tempus AI, Inc. (TEM)
CIK: 0001717115
--- Reporting Owner ---
Name: Schoenherr Thomas Edward
CIK: 0002113721
Role: Officer (CEO, Diagnostics)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Class A Common Stock
Date: 2026-09-25 | Code: S (Open market sale)
Shares: -10,281 | Price: $85.00
Total Value: $873,885.00
Shares Owned After: 76,740 | Ownership: D (Direct)
Footnotes:
[F1] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
--- Footnotes (Complete Index) ---
F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
--- Signature ---
/s/ /s/ Andrew Polovin, Attorney-in-Fact (2026-09-29)